Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation.

Cavalli, Giulio; Koenders, Marije; Kalabokis, Vassili; Kim, Jihye; Choon Tan, Aik; Garlanda, Cecilia; Mantovani, Alberto; Dagna, Lorenzo; Joosten, Leo A B; Dinarello, Charles A

Cavalli, Giulio; Koenders, Marije; Kalabokis, Vassili; Kim, Jihye; Choon Tan, Aik; Garlanda, Cecilia; Mantovani, Alberto; Dagna, Lorenzo; Joosten, Leo A B; Dinarello, Charles A.

Afiliação

Cavalli G; Department of Medicine, University of Colorado Denver, Aurora, CO, USA.
Koenders M; Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy.
Kalabokis V; Department of Internal Medicine.
Kim J; Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Choon Tan A; R&D Systems, BioTechne, Inc., Minneapolis, MN.
Garlanda C; Translational Bioinformatics, Division of Medical Oncology, University of Colorado Denver, Aurora, CO, USA.
Mantovani A; Translational Bioinformatics, Division of Medical Oncology, University of Colorado Denver, Aurora, CO, USA.
Dagna L; Research Institute Humanitas, Experimental Immunopathology Lab, Rozzano, Italy.
Joosten LAB; Research Institute Humanitas, Experimental Immunopathology Lab, Rozzano, Italy.
Dinarello CA; Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy.

Rheumatology (Oxford) ; 56(12): 2256, 2017 12 01.

Article em En | MEDLINE | ID: mdl-28968825

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google